Oct 29, 2025 06:09AM Silo Pharma, Inc. (SILO) files for 3.07M share offering by selling stockholders

Oct 23, 2025 08:45AM Silo Pharma advances PTSD drug trials, launches cryptocurrency treasury

Oct 8, 2025 08:45AM Silo Pharma makes first Bitcoin purchase as part of crypto strategy

Oct 6, 2025 08:10AM Silo Pharma purchases ResearchCoin tokens for digital asset strategy

Sep 9, 2025 09:10AM Silo Pharma receives Japanese patent for licensed PTSD drug SPC-15

Sep 3, 2025 08:25AM Silo Pharma receives Australian patent for PTSD drug candidate SPC-15

Aug 21, 2025 02:00PM Silo Pharma's Alzheimer's drug SPC-14 published in peer-reviewed journal

Aug 19, 2025 08:05AM Silo Pharma reports positive safety results for PTSD drug candidate

Aug 5, 2025 08:32AM Silo Pharma launches crypto treasury strategy with Bitcoin focus

Jul 16, 2025 08:45AM Silo Pharma completes dosing in PTSD drug safety study

Jul 7, 2025 08:16AM Silo Pharma expects preclinical data for PTSD drug SPC-15 within 90 days

Jun 25, 2025 08:38AM Silo Pharma (SILO) Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

Jun 25, 2025 08:29AM Hoth Therapeutics Inc. (HOTH) and Silo Pharma (SILO) form a 50/50 JV to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs

Jun 11, 2025 09:03AM Silo Pharma, Inc. (SILO) Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15

Jun 5, 2025 09:32AM Silo Pharma (SILO) stock surges on Bitcoin reserve move

Jun 5, 2025 09:15AM Silo Pharma (SILO) Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

May 21, 2025 08:56AM Silo Pharma (SILO) Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 15, 2025 09:15AM Silo Pharma, Inc. (SILO) Prices 3.33M Share Offering at $0.6/sh

May 14, 2025 04:08PM Silo Pharma (SILO) Selects Veloxity Labs for Bioanalytical IND-Enabling Study for SPC-15

May 14, 2025 08:40AM Silo Pharma (SILO) Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

Apr 30, 2025 08:11AM Silo Pharma's (SILO) SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Apr 28, 2025 07:50AM Silo Pharma (SILO) Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s Drug

Mar 26, 2025 08:43AM Silo Pharma, Inc. (SILO) announces first dosing in GLP study for SPC-15

Feb 26, 2025 01:30PM Silo Pharma (SILO) Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

Feb 18, 2025 08:51AM Silo Pharma (SILO) Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

Feb 11, 2025 07:45AM Silo Pharma (SILO) Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26

Jan 22, 2025 08:29AM Silo Pharma, Inc. (SILO) Announces Provisional Patent Filing for PTSD Treatment

Jan 8, 2025 08:29AM Silo Pharma (SILO) Awarded US Patent for PTSD Treatment

Jan 2, 2025 08:45AM Silo Pharma, Inc. (SILO) Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Dec 18, 2024 07:36AM Silo Pharma (SILO) Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia

Nov 29, 2024 08:05AM Silo Pharma (SILO) Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Nov 18, 2024 08:40AM Silo Pharma (SILO) Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

Sep 10, 2024 06:36AM Silo Pharma (SILO) Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

Aug 14, 2024 02:32PM Silo Pharma (SILO) Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

Aug 7, 2024 08:14AM Silo Pharma, Inc. (SILO) Announces Partnership with Global CRO

Jul 19, 2024 08:01AM Silo Pharma, Inc. (SILO) Announces $2.1 Million Registered Direct Offering of Common Stock, Warrants

Jul 18, 2024 08:25AM Silo Pharma (SILO) and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15

Jul 17, 2024 04:48PM Silo Pharma, Inc. (SILO) Files for up to 1.04M Share Offering by Selling Stockholders

Jul 16, 2024 06:30AM Silo Pharma (SILO) Secures Exclusive Global License for Alzheimer's Therapeutic

Jul 8, 2024 08:45AM Silo Pharma, Inc. (SILO) Enters Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders

Jun 26, 2024 08:51AM Silo Pharma (SILO) Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety